As Chief Scientific Officer, Rangaprasad (Ranga) Sarangarajan, Ph.D., leads Metabolon’s R&D teams to deliver metabolomics data and insights that expand and accelerate the impact of life sciences research in all its applications, including biopharma and diagnostics. Prior to Metabolon, he served as CSO and SVP of clinical and translational sciences at BERG, where he led multi-functional teams integrating biology, technology, and artificial intelligence analytics to develop a multi-omics, biology-based platform for the discovery of disease-specific and therapeutic targets and diagnostics development. Ranga obtained his Ph.D. in pharmaceutical sciences from the University of Cincinnati and a BS in pharmacy from Maharaja Sayajirao University.
.svg)
